Diabetic Retinopathy

Nona Biosciences Appoints Josh Xiao as New CSO

CAMBRIDGE, Mass., May 6, 2026 Nona Biosciences, a global biotechnology company specializing in biotherapeutic discovery and AI-driven drug development...

By cGxPwire Editor
May 7, 2026

M&A

Bayer to Acquire Perfuse Therapeutics in $2.45B Deal

BERLIN, Germany, and SAN FRANCISCO, Calif., May 6, 2026 Bayer has announced an agreement to fully acquire Perfuse Therapeutics...

By cGxPwire Editor
May 7, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Diabetic Retinopathy

Nona Biosciences Appoints Josh Xiao as New CSO

Bayer to Acquire Perfuse Therapeutics in $2.45B Deal